BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12169437)

  • 1. Metabolism of recombinant progastrin in sheep.
    Paterson AC; Baldwin GS; Shulkes A
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E449-56. PubMed ID: 12169437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity and regulation of stored and secreted progastrin-derived peptides in sheep.
    Paterson AC; Lockhart SM; Baker J; Neumann G; Baldwin GS; Shulkes A
    Endocrinology; 2004 Nov; 145(11):5129-40. PubMed ID: 15308616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and pathology of non-amidated gastrins.
    Shulkes A; Baldwin G
    Scand J Clin Lab Invest Suppl; 2001; 234():123-8. PubMed ID: 11713973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased tissue concentrations of the gastrin precursor in patients treated with omeprazole.
    Nemeth J; Varro A; Bridson J; Walker R; Dockray GJ
    Eur J Clin Invest; 1992 Oct; 22(10):638-44. PubMed ID: 1459168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM.
    Singh P; Velasco M; Given R; Wargovich M; Varro A; Wang TC
    Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G390-9. PubMed ID: 10712258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.
    Siddheshwar RK; Gray JC; Kelly SB
    Gut; 2001 Jan; 48(1):47-52. PubMed ID: 11115822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing and proliferative effects of human progastrin in transgenic mice.
    Wang TC; Koh TJ; Varro A; Cahill RJ; Dangler CA; Fox JG; Dockray GJ
    J Clin Invest; 1996 Oct; 98(8):1918-29. PubMed ID: 8878444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naming progastrin-derived peptides.
    Rehfeld JF; Bundgaard JR; Goetze JP; Friis-Hansen L; Hilsted L; Johnsen AH
    Regul Pept; 2004 Aug; 120(1-3):177-83. PubMed ID: 15177936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of progastrin derived peptides in colorectal carcinoma extracts.
    Nemeth J; Taylor B; Pauwels S; Varro A; Dockray GJ
    Gut; 1993 Jan; 34(1):90-5. PubMed ID: 8432459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gastrin component I as gastrin-71. The largest possible bioactive progastrin product.
    Rehfeld JF; Johnsen AH
    Eur J Biochem; 1994 Aug; 223(3):765-73. PubMed ID: 8055952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
    Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
    Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically active recombinant human progastrin(6-80) contains a tightly bound calcium ion.
    Baldwin GS; Hollande F; Yang Z; Karelina Y; Paterson A; Strang R; Fourmy D; Neumann G; Shulkes A
    J Biol Chem; 2001 Mar; 276(11):7791-6. PubMed ID: 11113148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of tissue progastrin concentrations in the rat.
    Varro A; Yegen B; Dockray GJ
    Exp Physiol; 1993 May; 78(3):327-36. PubMed ID: 8329207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo.
    Ottewell PD; Varro A; Dockray GJ; Kirton CM; Watson AJ; Wang TC; Dimaline R; Pritchard DM
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G541-9. PubMed ID: 15486344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antral content, secretion and peripheral metabolism of N-terminal progastrin fragments.
    Goetze JP; Hansen CP; Rehfeld JF
    Regul Pept; 2006 Jan; 133(1-3):47-53. PubMed ID: 16213037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of chromogranin A versus gastrin and progastrin in gastrinoma diagnosis and control.
    Rehfeld JF; Bardram L; Hilsted L; Goetze JP
    Biomark Med; 2014; 8(4):571-80. PubMed ID: 24796622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway.
    Patel O; Marshall KM; Bramante G; Baldwin GS; Shulkes A
    Regul Pept; 2010 Dec; 165(2-3):224-31. PubMed ID: 20727916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human gastrin precursor. Characterization of phosphorylated forms and fragments.
    Varro A; Desmond H; Pauwels S; Gregory H; Young J; Dockray GJ
    Biochem J; 1988 Dec; 256(3):951-7. PubMed ID: 3223964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progastrin and cyclooxygenase-2 in colorectal cancer.
    Konturek PC; Bielanski W; Konturek SJ; Hartwich A; Pierzchalski P; Gonciarz M; Marlicz K; Starzynska T; Zuchowicz M; Darasz Z; Götze JP; Rehfeld JF; Hahn EG
    Dig Dis Sci; 2002 Sep; 47(9):1984-91. PubMed ID: 12353842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17.
    Rehfeld JF; Zhu X; Norrbom C; Bundgaard JR; Johnsen AH; Nielsen JE; Vikesaa J; Stein J; Dey A; Steiner DF; Friis-Hansen L
    Biochem J; 2008 Oct; 415(1):35-43. PubMed ID: 18554181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.